• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Dexamethasone Sodium Phosphate Injection

 Status: Currently in Shortage

 » Date first reported: 01/15/2013
 » Therapeutic Categories: Dermatology; Gastroenterology; Hematology; Ophthalmology; Pediatric; Pulmonary/Allergy; Renal

American Regent/Luitpold (Reverified 09/22/2014)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/mL, 1 mL single dose vial (NDC 00517-4901-25) Unavailable- no product available for release. No plan to manufacture. American Regent is currently not manufacturing Dexamethasone Sodium Phosphate Injection, USP. Other
4 mg/mL, 5 mL multiple dose vial (NDC 00517-4905-25) Unavailable- no product available for release. No plan to manufacture. American Regent is currently not manufacturing Dexamethasone Sodium Phosphate Injection, USP. Other
4 mg/mL, 30 mL multiple dose vial (NDC 00517-4930-25) Unavailable- no product available for release. No plan to manufacture. American Regent is currently not manufacturing Dexamethasone Sodium Phosphate Injection, USP Other

Fresenius Kabi USA, LLC (Revised 09/11/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/mL, 1 mL single dose vial (NDC 63323-0165-01) Backordered. Next release anticipated September 2014. Check wholesalers for inventory on all presentations. Demand increase for the drug
20 mg/5 mL single dose vial (NDC 63323-0165-05) Available Check wholesalers for inventory on all presentations. Demand increase for the drug
120 mg/30 mL multiple dose vial (NDC 63323-0165-30) Backordered. Next release anticipated September 2014. Check wholesalers for inventory on all presentations. Demand increase for the drug
10 mg/mL, single dose vial (NDC 63323-0506-01) Available. Check wholesalers for inventory on all presentations. Demand increase for the drug
100 mg/10 mL multiple-dose vial (NDC 63323-0516-10) Backordered. Next release anticipated September 2014. Check wholesalers for inventory on all presentations Demand increase for the drug

Mylan Institutional (Reverified 09/02/2014)

Company Contact Information:
888-258-4199

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
120mg/30mL (4mg/mL) Pkg of 25 (NDC 67457-421-30) Available Demand increase for the drug
20mg/5mL (4mg/mL) Pkg of 25 (NDC 67457-422-54) Available Demand increase for the drug
4mg/mL Pkg of 25 (NDC 67457-423-12) Unavailable. Estimated recovery: October 2014 Demand increase for the drug
100mg/10mL (10mg/mL) Pkg of 10 (NDC 67457-420-10) Unavailable. Estimated recovery: October 2014 Demand increase for the drug

West-Ward Pharmaceuticals (Reverified 09/08/2014)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mL vial, 10 mg/mL (NDC 0641-0367-25) West-Ward currently has available inventory of this product. West-Ward has continued to acccelerate production on this product. Additional lots are scheduled for manufacturing with anticipated availability in the August – September 2014 timeframe. Increase in prooduct demand due to market supply issues.
-
-